| Old Articles: <Older 2221-2230 Newer> |
|---|
 |
Chemistry World
July 2, 2014
Phillip Broadwith |
Genentech to buy breast cancer specialist Seragon The deal gives Genentech access to Seragon's pipeline of investigational breast cancer therapies that work by destroying estrogen receptors on the surface of cancer cells.   |
Chemistry World
July 1, 2014
Hamish Crawford |
Graphene oxide stands the test of time Man has been eating graphene oxide in barbecued meat for millennia |
Chemistry World
June 30, 2014
Phillip Broadwith |
Inhaled insulin approved in US Mannkind's Affreza is aimed at reducing the need for patients to inject themselves with insulin so frequently. |
Chemistry World
June 30, 2014
James Urquhart |
Smell of malaria attracts mosquitoes The word 'malaria' means 'bad air', but new research suggests the disease may actually make its victims smell good to mosquitoes. |
Chemistry World
June 24, 2014
Elisabeth Ratcliffe |
Human protein cleans drinking water Researchers in Japan have shown that they can remove Escherichia coli from drinking water using tiny tubes made of human serum albumin. |
Chemistry World
June 20, 2014
Andy Extance |
Nickel allergy case highlights nanoparticle unknowns A report of a chemist who developed sensitivity to nickel after working with its nanoparticle form has highlighted how little we know about nanomaterial hazards. |
Chemistry World
June 16, 2014
Hepeng Jia |
Fatal toxins found in 'edible' wild mushrooms A wild mushroom eaten by foraging enthusiasts across Europe has been found to contain dangerous and potentially lethal toxins. |
Chemistry World
June 12, 2014
Andy Extance |
Pharma vies to unleash immune system power on cancer Drug firms are investing heavily in clinical trials and collaborations as they seek to capitalize on the potential of cancer therapies that enlist or enhance our immune systems' ability to fight tumors. |
AskMen.com
Chris Riddell |
Stress At Home A new study done by researchers at Penn State University discovered that people are actually more stressed at home than they are at work. |
Pharmaceutical Executive
June 9, 2014 |
Immunotherapies: The New Hope for Cancer Treatment The Cancer Research Institute is clearing a path to the future of immunotherapeutics. Ben Comer speaks to its CEO and director of scientific affairs, Jill O'Donnell-Tormey |
| <Older 2221-2230 Newer> Return to current articles. |
